SCHEMBL21610288

SCHEMBL21610288

C/C=C(\C)NCC(=O)NCCOC(c1ccccc1)(c1ccc(OC)cc1)c1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SLC6A11 P48066 4/20 0.45
▸ SLC6A1 P30531 2/20 0.45
▸ KMT2A Q03164 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ SLC6A12 P48065 1/20 0.41
▸ SLC6A13 Q9NSD5 1/20 0.41
▸ MTNR1A P48039 1/20 0.40
▸ MTNR1B P49286 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ CTDSP1 Q9GZU7 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16353467 0.78 SLC6A1 (0.44) SLC6A11SLC6A1SMN1; SMN2NPC1ALDH1A1
SCHEMBL22960803 0.78 HDAC6 (0.44) SLC6A11SLC6A1KMT2ASMN1; SMN2MEN1
SCHEMBL3931384 0.77 SLC6A11 (0.48) SLC6A11SLC6A1KMT2ASMN1; SMN2MEN1
SCHEMBL20799447 0.76 ALDH1A1 (0.50) SLC6A11SLC6A1SMN1; SMN2NPC1ALDH1A1
SCHEMBL23777331 0.75 SLC6A11 (0.47) SLC6A11SLC6A1KMT2ASMN1; SMN2MEN1
SCHEMBL16557240 0.75 HDAC6 (0.48) SLC6A11SLC6A1KMT2ASMN1; SMN2MEN1
SCHEMBL16218326 0.75 HDAC6 (0.48) SLC6A11SLC6A1KMT2ASMN1; SMN2MEN1
SCHEMBL16639379 0.75 HDAC6 (0.45) SLC6A11SLC6A1SMN1; SMN2NPC1ALDH1A1
SCHEMBL4066783 0.73 SLC6A11 (0.51) SLC6A11SLC6A1KMT2AMEN1TP53
SCHEMBL30861823 0.73 SLC6A11 (0.53) SLC6A11SLC6A1KMT2AMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10519446-B2 Organic compounds to treat hepatitis B virus NOVARTIS AG (CH) 2019-12-31 — — US disclosed
Send feedback